Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
176
Total Claims
$1.1M
Drug Cost
22
Beneficiaries
$51K
Cost/Patient
Risk Score Breakdown 32/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+416%
Opioid rate vs peers
32.4% vs 6.3% avg
+272%
Cost per patient vs peers
$51K vs $14K avg
+343%
Brand preference vs peers
64.8% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid rate is 416% above Hematology-Oncology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
32.4%
Opioid Rate
57
Opioid Claims
$3,996
Opioid Cost
24.6%
Long-Acting Rate
This provider's opioid prescribing rate of 32.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 114 claims · $1.1M
Generic: 62 claims · $17K
Patient Profile
59
Avg Age
—
Female
4.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About